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Цель. Исследование зависимости между нозологическими формами первых и вторых раков у па-
циентов, которые проходили специальное лечение по поводу онкологического заболевания и у которых 
возникли вторые раки через 3 года и более после окончания лечения.
Материал и методы. В исследовании проводилось сравнение между нозологической структурой вто-
рых раков, которые возникли у 203 пациентов, проходивших лечение по поводу онкологической пато-
логии, и официальными данными об удельном весе 10 основных нозологических форм злокачественных 
новообразований населения Украины. Статистическая значимость полученных результатов оценивалась с 
помощью доверительных интервалов, нормированных с учетом специфики контингента пациентов клини-
ки, где проводилось исследование.
Результаты. В соответствии с удельным весом нозологических форм первых раков, обусловлен-
ных, в первую очередь, специализацией клиники, обследуемые группы пациентов были разделены на 5 
нозологических подгрупп: пациенты с раком молочной железы, щитовидной железы, тела матки, шейки 
матки, рак яичников и с иными формами рака. Для каждой из подгрупп была исследована нозологическая 
структура вторых раков и сопоставлена с общей структурой злокачественных новообразований по данным 
официальной статистики. Показано, что частота пяти выделенных нозологических форм, рассчитанных 
для клиники, достаточно хорошо соответствует популяционному среднему, при этом для двух наиболее 
представительных нозологических форм соответствие находится в пределах ожидаемой стохастической из-
менчивости. Таким образом, показано, что не существует статистически значимых различий между про-
центным составом 10 основных нозологических форм рака населения Украины и структурой нозологиче-
ских форм вторых раков у исследуемой группы пациентов.
Заключение. Нозологическая форма вторых раков не является следствием первого рака, а воспроиз-
водит общую нозологическую структуру заболеваемости злокачественными новообразованиями.
Ключевые слова: первые раки, вторые раки, структура заболеваемости злокачественными новообразо-
ваниями, этиология вторых раков
Objective. To investigate the relationship between nosological forms of the primary and second neoplasms 
in patients who have undergone special treatment for cancer, and who have developed second neoplasms three and 
more years after the end of treatment.
Methods. The study has compared the nosological structure of second neoplasms that developed in 203 
patients undergoing treatment for oncological pathology with the official data on the specific weight of 10 major 
nosological forms of malignant neoplasms in Ukraine. The statistical significance of the obtained results has been 
estimated using confidence intervals normalized taking into account the specificity of the patients of the clinic where 
the study was conducted.
Results. In accordance with the specific weight of the nosological forms of the primary neoplasms, conditioned 
first by the specialization of the clinic, the study groups were divided into 5 nosological subgroups: patients with 
breast, thyroid, uterine, cervical, ovarian, and subgroup with other forms of cancer. For each of the subgroups, the 
nosological structure of the second neoplasms was investigated and compared with the overall structure of malignant 
neoplasms according to the official statistics. It is shown that the frequencies of five allocated nosological forms 
calculated for the clinic correspond fairly well to the population mean, while for two most representative nosological 
forms the correspondence is within the expected stochastic variability. Thus, it has been demonstrated that there are 
no statistically significant differences between the percentage composition of 10 major nosological forms of cancer 
in Ukraine and the structure of nosological forms of second neoplasms in the study group of patients.
Conclusions. The nosological form of second neoplasms is not a consequence of the primary cancer, but 
reproduces the overall nosological structure of the incidence of malignant neoplasms.
Keywords: primary neoplasms, second neoplasms, incidence structure of malignant neoplasms, etiology of second cancers
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Introduction
Effective methods of treatment and early 
diagnosis have resulted in a significant increase in 
the survival of cancer patients. For example, in the 
USA, the number of patients who have survived after 
the primary cancer is 3.5% and increases annually 
by almost 1,000,000 [1]. However, against the 
background of a general increase in life expectancy, 
another problem arises sharply: the problem of the 
secondary cancer [2]. According to statistical data, 
the incidence of recurrent neoplasms in surviving 
patients is 16% [3, 4].
Multiple primary malignant neoplasms or 
polyneoplasia are simultaneous or sequential 
formation of malignant tumors. They develop on 
their own and independently of each other within 
one or more organs of the human body. According 
to S.Ya. Maximov, 75% of polyneoplasias are 
hormone-dependent [5].
Multiple primary malignant tumors in 
accordance with the terms of their detection are 
usually divided into synchronous and metachronous 
or second cancers. The fact of prevalence of 
metachronous tumors of all localizations over 
synchronous is considered to be established.
Several hypotheses have been proposed to 
explain the fact of multiple lesions. Thus, for 
example, such therapeutic effects on the primary 
tumor as radiation therapy, polychemotherapy and 
immunosuppression are viewed as risk factors for 
second tumors development [6]. Another theory 
suggests that different cancers may have the same 
etiological factors, while the time of the agent’s 
action plays a decisive role in the emergence of 
several malignant tumors [7]. Immunodeficiency, 
heredity can also contribute to the development of 
recurrent cases of cancer in the same patient [8]. In 
addition, it is demonstrated that in the emergence 
of second neoplasms, age and sex matter [7, 8]. 
In particular, according to the literature data, 
women aged 41-60 years have a combination of 
hormone-dependent carcinomas [9]. It is believed 
that the prevalence of metachronous cancers in 
women compared with men is associated with a 
high frequency of polyneoplasia in the organs of 
reproductive system [8, 9].
The tendency of the body to form tumors, 
cancrophilia, is of great importance in the 
development of polyneoplasia [10, 11]. According 
to some reports, in 5-10% of patients who have 
survived the treatment of the primary cancer, the 
malignant process develops in another organ or 
tissue [11]. The Cancrophilia Syndrome includes 
hormonal metabolic shifts and disorders in the 
immune system that increase the probability of 
malignant transformation of cells under the influence 
of exogenous factors that create favorable conditions 
for the survival and progression of tumor clones [12, 
13]. It is shown that in persons cured of malignant 
tumors in childhood, the risk of developing the 
second tumor is 10 times higher than in patients 
whose tumors appeared in adulthood [12].
The probability of the appearance of second 
tumors increases in the presence of systemic 
disorders and with a decrease in the body’s defenses, 
as well as with the pronounced disturbance of 
homeostasis, in particular, when pro and antioxidant 
mechanisms are shifted toward oxidation [9, 14,]. 
Surgical treatment and chemoradiotherapy lead to 
further intensification of lipid peroxidation and to 
a decrease in the level of endogenous antioxidants. 
Thus, it becomes possible to induce the transition 
of the initiated cell into a transformed state, to 
accelerate the growth and metastasis of the primary 
tumor, which is explained by the significant 
biological and hormonal rearrangement of the body.
Ambiguous in its solution is the relationship 
between the nosological forms of the primary and 
second neoplasms. The overwhelming number of 
numerous foreign studies aimed at studying the 
problems of second neoplasms, are carried out 
within the framework of one primary oncological 
pathology and investigate the connections between 
the primary and second cancers, taking for the 
dogma the dependence of the second-cancer 
nosologies on the nosological form of the primary 
tumor [3, 16, 17]. 
Objective. To investigate the relationship 
between nosological forms of the primary and 
second neoplasms in patients who have undergone 
special treatment for cancer, and who have 
developed second neoplasms three and more years 
after the end of treatment
Methods
The study has been conducted on a 
multinasological block of follow-up data of 203 
cancer patients undergoing treatment at the clinic 
of SE "Institute of Medical Radiology named 
after S.P. Grigoriev" of the National Academy of 
Medical Sciences of Ukraine (the Institute) since 
1993 and who have developed second tumors three 
and more years after the treatment. Patients were 
treated according to the standard schemes that were 
used in accordance with the specific nosological 
form of the neoplasm. The schemes either included 
or not included surgical treatment, adjuvant and 
neoadjuvant radiation or chemotherapy in various 
combinations. When second malignant tumors 
developed, they were treated as primary ones. In 
some patients, the primary tumor was diagnosed in 
childhood, and at the Institute they were treated 
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for a second tumor and information about these 
patients was also taken into consideration. 
The fact of the second tumors development 
and their nosological forms were recorded in the 
electronic database used in the study only if there 
was an appropriate record in the patient's medical 
history, that is, if the patient addressed for help 
at the Institute's clinic and was there to treat 
the second tumor. Since the treatment of non-
melanoma skin diseases and malignant neoplasms 
of various parts of the intestine is not included in 
the list of the main areas of competence of the 
Institute, the history of patients with these forms of 
second cancer in the database has not been included 
or analyzed in most cases.
The median age of the patients at the onset time 
of the second malignant tumors was 50 years with 
a fluctuation from 4 years (patients with childhood 
cancers) to 81 years. The interquartile range of 
the sample was 42÷59 years. In the group there 
were 190 women (93.6%) and 13 (6.4%) men. The 
percentage composition of nosology of the primary 
cancers in patients with second tumors (group 
ST) reproduced the nosological orientation of the 
Institute's clinic: in 58% of patients (118) breast 
cancer was the primary, in 8% (17 people) – thyroid 
cancer, in 6% (13 people) – cancer of the uterus 
body, in 5% (10 people) – cervical cancer, in 4% (8 
people) – ovarian cancer, in 19% (37 people) other 
nosological forms. The median age of appearance of 
other cancers in the ST group was 59 years with a 
fluctuation from 30 to 83 years and an interquartile 
range of 52÷67 years. The time interval between 
tumors ranged from 3 to 40 years (the lower limit 
in patients with childhood cancers) with a median 
of 7 years and an interquartile range of 4÷12 years. 
The median timing of breast cancer after the 
treatment of the primary tumors was 7.2 years, 
uterine cancer – 7 years, cervical cancer – 6.7 
years, ovarian cancer – 5.6 years, thyroid cancer – 
10.8 years. 
The nosological structure of the second tumors 
was compared with the official data on the specific 
weight of the major nosological forms of malignant 
neoplasms of the Ukrainian population according 
to the bulletin of the Ukrainian National Cancer 
Registry No. 16 – "Cancer in Ukraine 2013-2014". 
For quantitative comparison, the following simple 
procedure was used. A certain set of common 
nosological forms of malignant neoplasms was 
considered. Based on the total number of cases from 
this set, the expected number of cases was calculated 
on the assumption that the probability of each of the 
considered nosological forms is proportional to the 
specific weight of this form according to the data 
of the cancer registry. Then, based on the total and 
expected number of cases, the prediction intervals 
(95%) of the stochastic spread was calculated using 
the binomial distribution: the lower bound of the 
interval was defined as the largest number of cases 
for which the cumulative binomial distribution is 
not greater than 0.025, and the upper limit is the 
smallest number, for which the cumulative binomial 
distribution is not less than 0.975. If the actual 
number of cases of this nosological form exceeds the 
calculated interval, this indicates that the frequency 
of this form in the studied sample is significantly 
different from the expected in accordance with its 
specific weight in Ukraine.
Conclusions
Based on official statistics, the most common 
nosological forms of cancer in Ukraine (Figure 1) 
were: breast (19.2%), non-melanoma malignant 
neoplasms (MN) of the skin (13.5%), uterine 
(9.0%), colon (6.6%), cervix (5.8%), rectum (5.0%), 
ovary (4.9%), stomach (4.8%), trachea, bronchi, 
lungs (3.8%), thyroid gland (3.5%), others (24.0%).
As part of the conducted study, a hypothesis has 
been put forward that the nosological form of second 
cancers is not a consequence of the primary cancer, 
but reproduces the overall nosological structure of 
the incidence of malignant neoplasms. The study 
of this issue consisted in comparing the structure 
of second cancers for each of the above nosological 
forms with the data of the national Cancer Registry.









































































were predominantly women, the right part of the 
bulletin data chart is of interest. As can be seen 
from Fig. 2, in patients with the first breast cancer, 
the overwhelming majority of second cancers were 
breast MN (46.6%), in the second place – the 
uterine (18.3%), in the third – ovaries (6.7%), in 
the 4th and 5th places – the thyroid gland (5.9%) 
and the cervix (3.4%).
Among the patients of the analyzed group with 
second tumors in 17 patients, the primary cancer 
was thyroid cancer. In 9 of them (53%) the second 
cancers belonged to 10 most common nosological 
forms. These were breast cancer, the uterus and 
ovaries cancers and their percentages coincided 
(16.7%).
The distribution of nosological forms of second 
neoplasms in patients treated for cancer of the uterus 
seems quite logical within the framework of our 
hypothesis. In the first place, as before, there was 
breast cancer 38.5% (5 patients), in the second – 
lung cancer (23.1%, 3 patients), in the third – colon 
cancer (15.4%, 2 patients), in the fourth – cancer 
of the rectum (7.7%, 1 patients). The tactics of 
treating such patients involves radical surgical 
intervention, as a result of which the absence of such 
nosologies as cancer of the uterus, cervical cancer 
and ovarian cancer in the list of second neoplasms 
is quite obvious. 
The nosological structure of the second MN 
in patients with cervical cancer is maximally 
approximated to the structure of the incidence of 
breast cancer in women in Ukraine: the first place 
occupies breast cancer (6 patients, 60%), the second 
– cancer of the uterus body (2 patients, 20%) and 
one case of lung cancer and melanoma. 
Among the 8 patients treated for ovarian cancer 
and surviving to the second tumor, in five women 
(62.5%) the second tumor was in the breast, the 
remaining three women developed ovarian cancer, 
thyroid cancer and intestinal cancer (12 ,5 %).
Very limited (due to atypical nosology for 
treatment in the clinic of the Institute) was a sample 
of patients treated for MN of the rectosigmoidal 
junction. The nosological structure of the second 
cancers in this group of patients also corresponded 
to our hypothesis. Among only 5 patients, all three 
of the most common cancers were diagnosed: breast, 
uterine and cervical cancers.
The last diagram demonstrating the structure of 
second neoplasms for patients united in the category 
of "other first cancers" is quite indicative. The 
nosological forms presented in this category were 
significantly less frequent than those considered 
above (Figure 3). As can be seen, almost all 
nosologies from the top of the disease incidence 
diagram for women in Ukraine are also present here.
Similarly, to the nosological structure of the 
first cancers in the study group of patients, of which 
(structure) has been already mentioned above, the 
nosological structure of the second cancers also had 
a somewhat biased character in favor of "typical" 
forms for the clinic. In particular, there were no skin 
tumors in the analyzed data block and the number 
of patients with intestinal tumors was limited. Thus, 
initially the sample of those patients who have 
undergone treatment at the Institute and who had 
Fig. 2. The most common nosological forms of second cancers in breast cancer patients, %: A – in women of Ukraine; 
B – women of the research group.
Fig. 3. The most common nosological forms of second cancers in patients with other forms of cancer, %: A – in women 
of Ukraine; B – women of the research group.
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second cancers after the treatment of the primary 
cancers was censored in nature, as not all patients 
returned to the Institute for the treatment of second 
cancers. In this regard, to verify the statistical 
significance of the results, the representativeness of 
the sample should be justified. To do this, in the 
study, for each of five most common nosological 
forms, a comparison was made of the actual number 
of cases of each cancer with the prediction of their 
number based on the disease incidence in Ukraine 
on this nosology. 
Figure 4 illustrates the data for 166 patients 
with the primary cancer among five most common 
nosological forms. The circles show the actual 
number of cases of the primary cancer forms in this 
study, the rhombuses – the expected number of 
cases for the same nosological forms, calculated in 
accordance with the structure of the MN incidence 
in women in Ukraine, and the lines bounded by 
vertical strokes are formal 95% prediction intervals 
for stochastic scattering.
The figure clearly shows that the cancer of 
the uterus, cervix and ovarian cancer in the used 
data set are not representative and the number of 
these patients differs from national statistics in 
the direction to “less” and all the shifts are quite 
comparable. This is due to the fact that Kharkov 
is a major medical center in Ukraine, and patients 
have alternatives for choosing an institution to 
perform complex diagnostics and treatment of these 
nosologies. However, for treatment of breast cancer 
and thyroid cancer, the Institute is the leading 
medical establishment not only in Kharkov, but 
also in Ukraine.
Figure 5 shows that if we take into consideration 
only breast cancer and thyroid cancer and 
recalculate the national average of their frequencies, 
then the resulting ratio is ideally reproduced in the 
investigated dataset. 
Similarly, Figures 6 and 7 compare the 
incidence of second cancers among five most 
common nosological forms for patients with the 
primary breast cancer with the predicted national 
averages of frequencies for the set of only these 
five forms.
As can be seen from Fig. 6, the frequencies 
of five identified nosological forms calculated for 
the Institute correspond fairly well to the average 
in Ukraine, and for two most representative 
nosological forms (Figure 7), the correspondence 
is within the expected stochastic variability. 
It should be noted that the authors have also 
carried out a serious work to study the possible 
connection between the factors of treatment of the 
primary cancers (ionizing radiation, chemotherapy) 
and second tumors. At the same time, no direct 
correlation has been revealed.
Discussion
In the given study, the group of patients who 
have developed second tumors at distant post-
treatment periods was divided into subgroups 
according to the nosological forms of the primary 
cancers. For each subgroup, the nosological 
structure of the second cancers was examined 
and compared with the official statistics. The 
conducted studies demonstrate that if we abandon 
the quantitative scale of measurement and move 
to the ordinal scale with the relations "more, less, 
equal to each other" then, in comparison with the 
structure of the MN in Ukraine, the order is not 
always preserved only on the last nosologies; this 
fact is quite understandable taking into account 
relatively low for this group absolute percentages. 
Especially visually the obtained results are 
traced on a sample of patients with the primary 
breast cancer, since this cohort of patients is the 
most characteristic for the Institute's clinic and, 
accordingly, the most numerous. Unlike the 
Fig. 4. Comparison of the actual number of cases of the 
primary cancer among 5 most common nosological forms 
with the expected number based on the MN incidence in 
Ukraine on this nosology.
Fig. 5. Comparison of the actual number of cases of breast 
cancer and thyroid cancer with their expected number 
based on the MN incidence in Ukraine on this nosology.
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Fig. 6. Comparison of the cases number of 5 nosological 
forms of the second cancer for the primary breast cancer 
with the expected number of cases based on the MN 
incidence in Ukraine according on this nosology.
Fig. 7. Comparison of the actual number of cases of the 
second cancer from the number of nosological forms most 
fully represented in the studied dataset for the primary 
breast cancer with the expected number of them based on 
the MN incidence in Ukraine on this nosology.
commonly held opinion that the most likely second 
cancer in case of this nosology is contralateral breast 
cancer [18], we have shown that not nosology 
determines the type of the second cancer, but its 
frequency in the structure of the overall incidence of 
the population. The necessary statistical processing 
has been carried out in the study to justify the 
representativeness of the sample being studied. 
For this purpose, for each of the nosological 
subgroups of the primary neoplasms, the actual 
number of cases of each cancer was compared 
with the prediction of their number based on the 
MN incidence in Ukraine for each nosology, in 
particular, for the breast. Besides, an additional 
argument for the representativeness of the studied 
sample is the comparison of our results with 
the SEER (Surveillance Epidemiology and End 
Results): among 328 691 clinical cases of the first 
breast cancer registered in SEER from 1973 to 2000, 
182,057 cases were selected when patients have lived 
5 or more years. The second tumor developed in 15 
498 patients (8.5%), in particular, in 6491 (42%) 
cases it was cancer of the contralateral breast [3]. 
As can be seen from Fig. 2, in the sample that 
was used in our study, contralateral breast cancer 
developed in 46.6% of patients, that is, the results 
appeared to be very close. The discrepancy in the 
data in the direction to "more" in the studied sample 
is due to the fact that the overwhelming number 
of patients treated for the primary breast tumor in 
the Institute’s clinic remain for further observation 
and are examined there, without addressing for the 
treatment of contralateral breast cancer to other 
medical institutions.
A fairly convincing argument is also the results 
of remote observations of 37 patients out of 203, 
in whom the second cancer did not belong to 5 
most frequent nosological forms. Such cancers were 
categorized as "others" (ICD codes: C64, C91, C85, 
C81, C67, C64, C52, C51, C49, C44, C43, C37, 
C32, C20, C19, C18, C16). Analysis of the structure 
of second cancers also revealed the dominant of five 
basic nosological forms of the population structure.
Thus, it can be stated that the existing data set 
hasn’t revealed statistically significant dependencies 
between treatment factors and the development of 
second cancers.
Attention is drawn to the fact that both 
primary tumors and second neoplasms are hormone 
dependent, and therefore we do not exclude that 
certain changes in the endocrine system are the 
basis of the revealed patterns. This conclusion, of 
course, is a priori and needs additional verification 
by means of an increase in the number of samples.
Conclusions
In this paper, the study results of s the 
relationship between the nosological forms of the 
primary and second neoplasms in patients who 
have undergone special treatment for oncological 
disease in the clinic of SE "Institute of Medical 
Radiology named after S.P. Grigoriev" of the 
National Academy of Medical Sciences of Ukraine 
and who have developed second cancers three and 
more years after the end of treatment. 
In accordance with the specific weight of the 
nosological forms of the primary cancers, due 
mainly to the specialization of the Institute's clinic, 
the patients of the study group were divided into 
5 nosological subgroups: patients with cancers of 
the breast, thyroid, uterine, cervical, ovarian and 
subgroup with other forms of cancers. For each 
of the subgroups, the nosological structure of the 
second cancers was investigated and compared 
with the overall structure of malignant neoplasms 
according to official statistics. It is shown that the 
frequencies of five allocated nosological forms 
calculated for the Institute correspond fairly 
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well to the population mean, while for two most 
representative nosological forms the correspondence 
is within the expected stochastic variability. Thus, it 
has been demonstrated that there are no statistically 
significant differences between the percentage 
composition of 10 major nosological forms of cancer 
in Ukraine and the structure of nosological forms 
of second cancers in the study group of patients.
The work was carried out in accordance with the 
research plan of SE "Institute of Medical Radiol-
ogy named after S.P. Grigoriev" of the National 
Academy of Medical Sciences of Ukraine.
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